-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse NasdaqUSDISIN US33938J1060-
FLEXION THERAPEUTICS INCBörse Börse DüsseldorfEURSymbol F02
-
FLEXION THERAPEUTICS INCBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol F02
-
FLEXION THERAPEUTICS INCBörse Börse MünchenEURSymbol F02
-
FLEXION THERAPEUTICS INCBörse Gettex System der Börse MünchenEURSymbol F02
-
FLEXION THERAPEUTICS INCBörse Quotrix System der Börse DüsseldorfEURSymbol F02
-
Flexion TherapeuticsBörse NasdaqISIN US33938J1060 WKN: A1XEDRUSDSymbol FLXN
-
ISIN US33938J1060 WKN: A1XEDRUSDSymbol FLXN
-
EURSymbol F02
-
EURSymbol F02
-
ISIN US33938J1060
WKN A1XEDR
Symbol FLXN
Währung
USD
Börse
Nasdaq Zeitzone: Europe/Berlin
Firmenname
Flexion Therapeutics, Inc
Marktkapitalisierung
452.996.000 (+- 27%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
576.992.000 oder 329.000.000
Mitarbeiter
273 (+- 6%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
288 oder 257 Mitarbeiter
EBITDA -150.407.008
Buchwert 0.335
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 9,81 USD +0,71%
Portrait der Flexion Therapeutics Aktie
Das Unternehmen Flexion Therapeutics, Inc aus USA beschäftigt 273 Mitarbeiter.
Das Unternehmen Flexion Therapeutics, Inc ist nur in 5 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter iShares Nasdaq US Biotechnology UCITS ETF gewichtet Flexion Therapeutics mit 0,02% im ETF.
5 ETFs die in Flexion Therapeutics investieren
Dir gefallen die Informationen zu Flexion Therapeutics?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Flexion Therapeutics?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Flexion Therapeutics?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Flexion Therapeutics?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
29 News & Informationen zur Flexion Therapeutics Aktie
Strongbridge Biopharma : Certain Litigation Relating to the Transaction (Form 8-K)
Certain Litigation Relating to the Transaction
As previously disclosed, on May 24, 2021, Strongbridge Biopharma plc entered into a Transaction Agreement with Xeris… | August 30, 2021
54 Biggest Movers From Yesterday
Gainers Regencell Bioscience Holdings Limited (NASDAQ:RGC) shares jumped 202.8% to settle at $46.33 on Wednesday after gaining over 11% on Tuesd…
Flexion Therapeutics Announces Expansion of Phase 1b Trial Investigating FX301 for the Management of Post-Operative Pain
Initial findings from proof-of-concept trial in patients undergoing bunionectomy support expansion of the study to include 36 additional patientsData from…
Miller Value Partners, Llc Buys Splunk Inc, Metromile Inc, SoFi Technologies Inc, Sells Workday Inc, Discovery Inc, Flexion Therapeutics Inc
GuruFocus Article or News written by insider and the topic is about:
60 Biggest Movers From Yesterday
Gainers Trillium Therapeutics Inc. (NASDAQ:TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pf…
Clearline Capital LP Buys Array Technologies Inc, Green Dot Corp, Rexnord Corp, Sells Facebook Inc, Skillsoft Corp, EchoStar Corp
GuruFocus Article or News written by insider and the topic is about:
Why Flexion Therapeutics (FLXN) Could Be an Impressive Growth Stock
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Flexion Therapeutics (FLXN).
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc. (NYSE: BIO) Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) Gilead Sciences, Inc. (NASDAQ: GILD) GlaxoSmithKline plc (NYSE: GSK) Johnson & Johnson (NYSE: JNJ) Laboratory Corporation of America Holdings (NYSE: LH) Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) NanoVibronix, Inc. (NASDAQ: NAOV) (announced intention to enter over-
Down 24.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Flexion Therapeutics (FLXN)
The heavy selling pressure might have exhausted for Flexion Therapeutics (FLXN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Stocks That Hit 52-Week Lows On Friday
Friday morning, 94 companies reached new 52-week lows.
Significant Points: Wix.com (NASDAQ:WIX) is the largest company in terms of market cap …
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Au…
Flexion Therapeutics, Inc. 2021 Q2 – Results – Earnings Call Presentation (NASDAQ:FLXN)
The following slide deck was published by Flexion Therapeutics, Inc.
Flexion Therapeutics, Inc. (FLXN) CEO Michael Clayman on Q2 2021 Results – Earnings Call Transcript
Flexion Therapeutics, Inc. (NASDAQ:FLXN) Q2 2021 Earnings Conference Call August 4, 2021 4:30 PM ET Company Participants Scott Young – Vice President, Corporate Communications and Investor…
Flexion Therapeutics, inc (FLXN) Q2 2021 Earnings Call Transcript
FLXN earnings call for the period ending December 31, 2020.
Flexion Therapeutics To Report Second-Quarter 2021 Financial Results On August 4, 2021
BURLINGTON, Mass., July 29, 2021 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it will report its second-quarter 2021
Joint Pain Injections Market Report 2021-2028 | Size, Share, Growth, Trends, Revenue, Competitive Landscape, Analysis, Forecast
Top Players Covered in the Joint Pain Injections Market Research Report Are Anika Therapeutics, Inc., Teva Pharmaceuticals Industries Ltd., Flexion…
Asensus Surgical Announces The Appointment Of Two New Board Members
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era
Zazove Associates Llc Buys Skillz Inc, Landsea Homes Corp, Flexion Therapeutics Inc, Sells GDL Fund, NovoCure, Microchip Technology Inc
GuruFocus Article or News written by insider and the topic is about:
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Ju…
Entasis Therapeutics Expands Executive Leadership Team with the Appointment of Anna Diaz Triola as Chief Commercial Officer
– Significant commercial strategy and product launch experience –– ATTACK Phase 3 top-line data readout remains on-track for 2H 2021 – WALTHAM, Mass.,…
Entasis Therapeutics Expands Executive Leadership Team With The Appointment Of Anna Diaz Triola As Chief Commercial Officer
– Significant commercial strategy and product launch experience – – ATTACK Phase 3 top-line data readout remains on-track for 2H 2021 –
WALTHAM, Mass., July
Flexion Therapeutics Announces Appointment of Utpal Koppikar to its Board of Directors
BURLINGTON, Mass., July 12, 2021 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced the appointment of Utpal Koppikar, Chief…
ANI Pharmaceuticals Inc (ANIP) Fell Out Of Favor With Hedge Funds
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data….
EDGAR Filing Documents for 0000950170-21-000394
Wasatch Advisors established new holdings in StepStone Group Inc. By Investing.com
Wasatch Advisors established new holdings in StepStone Group Inc.
Flexion Therapeutics anticipates Q4 Zilretta sales of $26.3M (NASDAQ:FLXN)
Flexion Therapeutics Announces Preliminary, Unaudited Fourth-Quarter And Full-Year 2020 Results
Fourth-quarter 2020 ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) net sales estimated to be approximately $26.3 million
Flexion Therapeutics Announces Preliminary, Unaudited Fourth-Quarter and Full-Year 2020 Results
Fourth-quarter 2020 ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) net sales estimated to be approximately $26.3 milli…
Global Osteoarthritis Therapeutics Market (2020 to 2025) – Personalized Medicines for Osteoarthritis Presents Opportunities
/PRNewswire/ — The “Global Osteoarthritis Therapeutics Market by Anatomy (Knee, Hand), Drug Type (NSAIDs, Analgesics, Corticosteroids), Route of…